The role of the integrin vitronectin receptor, ?v?3 in melanoma metastasis
- 1 September 1995
- journal article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 14 (3) , 241-252
- https://doi.org/10.1007/bf00690295
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.Journal of Clinical Investigation, 1995
- Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosisCardiovascular Research, 1994
- Vitronectin and its receptorsCurrent Opinion in Cell Biology, 1993
- The plasminogen-plasmin system in malignancyCancer and Metastasis Reviews, 1992
- Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: A key event in melanoma cell invasiveness in vitroExperimental Cell Research, 1992
- Affinity of integrins for damaged extracellular matrix: αvβ3 binds to denatured collagen type I through RGD sitesBiochemical and Biophysical Research Communications, 1992
- Identification of a Melanoma Progression Antigen as Integrin VLA-2Journal of Investigative Dermatology, 1991
- Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectinCell Differentiation and Development, 1990
- Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells.The Journal of cell biology, 1990
- Plasminogen Activator Released as Inactive Proenzyme from Murine Cells Transformed by Sarcoma VirusEuropean Journal of Biochemistry, 1982